Poa Pharma Scandinavia AB

POA Pharma strengthening its ownership in US distributor

Pressmeddelande   •   Dec 15, 2015 20:27 CET

In december 2014 POA Pharma Scandinavia AB acquired a 20 percent stake in Novam-Nutrition LLC, Oregon, USA and along with this also a directorship. Last month POA Pharma increased its ownership to 70 percent and changed the company name of Novum-Nutrition to POA Pharma North America.

Thus, POA Pharmas world wide expansion continues to be very strong.

– Next year we will be selling in 42 countries, says CEO Tina Madsen Sandström.

POA Pharma Scandinavia AB with offices in Gothenburg, Bergen, Hillerod and Helsinki primarily markets Pharmaceuticals and Medical Nutrition.(wwwpoapharma.com)

–The US and Canada market is strategically important within our Medical Nutrition area and we expect an interesting development in the near future, says Tina Madsen Sandström.

The main focus for POA Pharma North America will be marketing of medical nutrition in Canada and the United States. 

The two key product groups within Medical Nutrition are important parts of the cooperation:

  • Anti-secretory factor, AF, in the form of the products SPC-Flakes and Salovumfor the treatment of inflammatory bowel diseases, Meniere’s disease, Mastitis and other disorders. AF is a Swedish research project based in Gothenburg and POA Pharma holds the global rights.
  • In-house developed and manufactured products within the area of PKU, an inherited metabolic disorder that requires daily and lifelong treatment. Phenylketonuria - also known as PKU - is a rare inherited disorder that causes the anaminoacid called phenylalanine to build up in your body.

Both product groups are eligible for reimbursement in most countries, i.e. authorities pay for most of the treatment cost due to the vital importance of the treatment.

 Says David Lindsley, CEO of POA Pharma North America:

– We are exited for the increase in co-ownership of the business as it will provide us with resources to strengthen the POA Pharma footprint within Medical Nutrition.

The availability of a total of 42 markets from 2016 will provide the POA Pharma continues significant growth in the coming years.

Questions will be answered by Tina Madsen Sandström at tina.madsen@poaab.com

Press contacts:

Carl-Olof Borjeson

+46 73-703 24 72 

POA Pharma är en ny typ av läkemedels- och hälsoföretag; litet, snabbrörligt, lyhört med fokus på kompetens. POA står för Point Of Action, ”en Boutique health firm” en ny startpunkt för ett aktivt samspel med sjukvården till fromma för patienter och samhälle, ett drivhus där impulser och idéer växer och frodas och leder till bättre vård.